PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization

Journal of Bone and Mineral Research

Volumn 31, Issue 1, 2016, Pages 180-189

  Misof, Barbara M ^a   Roschger, Paul ^a   Dempster, David W ^b,c   Zhou, Hua ^b   Bilezikian, John P ^c   Klaushofer, Klaus ^a   Rubin, Mishaela R ^c  

^a HANUSCH HOSPITAL   (Austria)

^b HELEN HAYES HOSPITAL   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

BMDD; BONE MINERALIZATION DENSITY DISTRIBUTION; HYPOPARATHYROIDISM; QBEI; QUANTITATIVE BACKSCATTERED ELECTRON IMAGING; TRANSILIAC BONE BIOPSY

Indexed keywords

PARATHYROID HORMONE;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE MINERALIZATION; BONE TURNOVER; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HUMAN; HUMAN TISSUE; HYPOPARATHYROIDISM; MALE; MORPHOMETRICS; OSSIFICATION; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; TRABECULAR BONE; TREATMENT DURATION; BONE REMODELING; DRUG EFFECTS; METABOLISM; MIDDLE AGED; PATHOLOGY; TIME FACTOR;

ADULT; BONE DENSITY; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; COHORT STUDIES; FEMALE; HUMANS; HYPOPARATHYROIDISM; MALE; MIDDLE AGED; PARATHYROID HORMONE; TIME FACTORS;

EID: 84957707158     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2588     Document Type: Article

References (33)

1. Sikjaer T, Rolighed L, Hess A, Fuglsang-Frederiksen A, Mosekilde L, Rejnmark L., Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int. 2014 Jun; 25 (6): 1717-26.
2. Cusano NE, Rubin MR, McMahon DJ, et al., PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J Clin Endocrinol Metab. 2014 Oct; 99 (10): 3694-9.
3. Rubin MR, Dempster DW, Kohler T, et al., Three dimensional cancellous bone structure in hypoparathyroidism. Bone. 2010 Jan; 46 (1): 190-5.
4. Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P., Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone. 1996; 18 (2): 103-8.
5. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL., Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest. 1982 Jun; 69 (6): 1302-9.
6. Clarke BL., Bone disease in hypoparathyroidism. Arq Bras Endocrinol Metabol. 2014 Jul; 58 (5): 545-52.
7. Fujiyama K, Kiriyama T, Ito M, et al., Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. J Clin Endocrinol Metab. 1995 Jul; 80 (7): 2135-8.
8. Winer KK, Ko CW, Reynolds JC, et al., Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab. 2003 Sep; 88 (9): 4214-20.
9. Winer KK, Fulton KA, Albert PS, Cutler GB Jr., Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism. J Pediatr. 2014 Sep; 165 (3): 556-63.e1.
10. Rejnmark L, Underbjerg L, Sikjaer T., Therapy of hypoparathyroidism by replacement with parathyroid hormone. Scientifica (Cairo). 2014; 2014: 765629.
11. Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP., Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int. 2010 Nov; 21 (11): 1927-34.
12. Rubin MR, Dempster DW, Sliney J Jr, et al., PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res. 2011 Nov; 26 (11): 2727-36.
13. Sikjaer T, Rejnmark L, Thomsen JS, et al., Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res. 2012 Apr; 27 (4): 781-8.
14. Gafni RI, Brahim JS, Andreopoulou P, et al., Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res. 2012 Aug; 27 (8): 1811-20.
15. Roschger P, Fratzl P, Eschberger J, Klaushofer K., Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 1998; 23: 319-26.
16. Roschger P, Paschalis EP, Fratzl P, Klaushofer K., Bone mineralization density distribution in health and disease. Bone. 2008; 42: 456-66.
17. Roschger P, Gupta HS, Berzlanovich A, et al., Constant mineralization density distribution in cancellous human bone. Bone. 2003; 32: 316-23.
18. Misof BM, Dempster DW, Zhou H, et al., Relationship of bone mineralization density distribution (BMDD) in cortical and cancellous bone within the iliac crest of healthy premenopausal women. Calcif Tissue Int. 2014; 95 (4): 332-9.
19. Boivin G, Meunier PJ., The degree of mineralization of bone tissue measured by computerized quantitative contact microradiography. Calcif Tissue Int. 2002; 70: 503-11.
20. Roschger P, Misof B, Paschalis E, Fratzl P, Klaushofer K., Changes in the degree of mineralization with osteoporosis and its treatment. Curr Osteoporos Rep. 2014 Sep; 12 (3): 338-50.
21. Theman TA, Collins MT, Dempster DW, et al., PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. J Bone Miner Res. 2009 May; 24 (5): 964-73.
22. Misof BM, Roschger P, Cosman R, et al., Effects of intermittent parathyroid hormone administration on bone mineralization density distribution in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab. 2003; 88: 1150-6.
23. Misof BM, Paschalis EP, Blouin S, Fratzl-Zelman N, Klaushofer K, Roschger P., Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate. J Bone Miner Res. 2010 Nov; 25 (11): 2297-303.
24. Arlot M, Meunier PJ, Boivin G, et al., Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res. 2005 Jul; 20 (7): 1244-53.
25. Paschalis EP, Glass EV, Donley DW, Eriksen EF., Bone mineral and collagen quality in iliac crest biopsies of patients given teriparatide: new results from the fracture prevention trial. J Clin Endocrinol Metab. 2005 Aug; 90 (8): 4644-9.
26. Jobke B, Muche B, Burghardt AJ, Semler J, Link TM, Majumdar S., Teriparatide in bisphosphonate-resistant osteoporosis: microarchitectural changes and clinical results after 6 and 18 months. Calcif Tissue Int. 2011 Aug; 89 (2): 130-9.
27. Stepan JJ, Burr DB, Li J, et al., Histomorphometric changes by teriparatide in alendronate-pretreated women with osteoporosis. Osteoporos Int. 2010 Dec; 21 (12): 2027-36.
28. Ma YL, Zeng QQ, Chiang AY, et al., Effects of teriparatide on cortical histomorphometric variables in postmenopausal women with or without prior alendronate treatment. Bone. 2014 Feb; 59: 139-47.
29. Ruffoni D, Fratzl P, Roschger P, Phipps R, Klaushofer K, Weinkamer R., Effect of temporal changes in bone turnover on the bone mineralization density distribution: a computer simulation study. J Bone Miner Res. 2008 Dec; 23 (12): 1905-14.
30. Roschger P, Dempster DW, Zhou H, et al., New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging. J Bone Miner Res. 2007; 22: 717-23.
31. Fratzl P, Roschger P, Fratzl-Zelman N, Paschalis EP, Phipps R, Klaushofer K., Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Calcif Tissue Int. 2007; 81: 73-80.
32. Misof BM, Patsch JM, Roschger P, et al., Intravenous treatment with ibandronate normalizes bone matrix mineralization and reduces cortical porosity after two years in male osteoporosis: a paired biopsy study. J Bone Miner Res. 2014 Feb; 29 (2): 440-9.
33. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L,. Postsurgical hypoparathyroidism-risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014; 29: 2504-10.